Transgene Biotek Limited submitted a regulatory disclosure to BSE Limited regarding the outcome of its Board of Directors meeting held on October 10, 2026, from 11:00 A.M. to 12:30 P.M.
The Board approved the appointment of M/s. Eswara Rao & Co., Chartered Accountants (Firm Registration No. 000816S) as the Statutory Auditors of the Company. The firm will be represented by Ms. Karra Pranavi, Partner (Membership No. 232994).
This appointment is to fill the casual vacancy arising due to the resignation of the previous statutory auditors, M/s. Vasavi & Co., Chartered Accountants. The appointment is subject to approval by the company's members at a general meeting, in accordance with the applicable provisions of the Companies Act, 2013.
The Board noted that it had received the consent letter, eligibility certificate, and other applicable confirmations from the proposed Statutory Auditors.
This intimation is submitted pursuant to the applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, following an earlier intimation dated October 2, 2026.
The disclosure was signed by Dr. K Koteswara Rao, Managing Director (DIN: 02287235).